The interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
Study Goal
The researchers aimed to evaluate the effectiveness of a low-carbohydrate diet compared to traditional high-carbohydrate, low-fat diets in managing type 2 diabetes.
Results Summary
The study found that a low-carbohydrate diet may improve HbA1c, triglycerides, and HDL cholesterol levels, and reduce diabetes medication requirements, though medication reduction may have masked some benefits. Meta-analyses showed statistically significant improvements in HbA1c at 1 year.
Population
Adults aged 18+ with type 2 diabetes.
Effective Dosage
Not specified (varied by study).
Duration
Data analyzed up to 1 year.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
low-carbohydrate diet | decrease | HbA1c | adults with type 2 diabetes | - | may promote favourable outcomes | #1 |
low-carbohydrate diet | decrease | triglycerides | adults with type 2 diabetes | - | may promote favourable outcomes | #2 |
low-carbohydrate diet | increase | HDL cholesterol | adults with type 2 diabetes | - | may promote favourable outcomes | #3 |
low-carbohydrate diet | decrease | diabetes medication | adults with type 2 diabetes | - | demonstrated reduced requirements | #4 |
low-carbohydrate diet | decrease | HbA1c | adults with type 2 diabetes | -0.28% | showed statistical significance in favour | #5 |
low-carbohydrate diet | neutral | management of type 2 diabetes | adults with type 2 diabetes | - | may produce clinical improvements | #6 |
BACKGROUND/OBJECTIVES: Recently, the role of a low-carbohydrate diet in diabetes management has generated interest with claims being made regarding its superiority over the traditional high-carbohydrate, low-fat dietary approach. This systematic review and meta-analysis evaluated the interpretation and effect of a low-carbohydrate diet in the management of type 2 diabetes. SUBJECTS/METHODS: Randomised controlled trials were searched for which included adults with type 2 diabetes aged 18 years or more. The intervention was a low-carbohydrate diet as defined by the author compared to a control group of usual care. MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, ISRCTN, ProQuest and opengrey.eu were searched. Independent experts were contacted and reference lists of selected papers were checked. Results were analysed descriptively and meta-analyses were completed to include trials that presented data at 1 year. RESULTS: Eighteen studies (n = 2204) were eligible for inclusion within the systematic review. The definition of a low-carbohydrate diet varied. At trial end, the descriptive analysis suggested that the low-carbohydrate intervention arm (LCIA) may promote favourable outcomes in terms of HbA1c, triglycerides and HDL cholesterol. The LCIA demonstrated reduced requirements for diabetes medication, which may have reduced the observed benefit of dietary carbohydrate restriction on HbA1c. Seven studies provided data to be included in the meta-analyses at 1 year. The meta-analyses showed statistical significance in favour of the LCIA for HbA1c (estimated effect = -0.28%, 95% CI -0.53 to -0.02, p = 0.03; χ CONCLUSIONS: Reducing dietary carbohydrate may produce clinical improvements in the management of type 2 diabetes. Further research is needed to understand the true effect of dietary carbohydrate restriction on HbA1c independent of medication reduction and to address known issues with adherence to this dietary intervention. Clarity is needed regarding appropriate classification of a low-carbohydrate diet.